Cited by 175Menopause: Health Impacts and TreatmentsEstrogen and related hormone effectsHormonal and reproductive studies

Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment

Flores, Valerie A, Pal, Lubna, Manson, JoAnn E·2021·Endocrine Reviews

Abstract

Hormone therapy (HT) is an effective treatment for menopausal symptoms, including vasomotor symptoms and genitourinary syndrome of menopause. Randomized trials also demonstrate positive effects on bone health, and age-stratified analyses indicate more favorable effects on coronary heart disease and all-cause mortality in younger women (close proximity to menopause) than in women more than a decade past menopause. In the absence of contraindications or other major comorbidities, recently menopausal women with moderate or severe symptoms are appropriate candidates for HT. The Women’s Health Initiative (WHI) hormone therapy trials—estrogen and progestin trial and the estrogen-alone trial—clarified the benefits and risks of HT, including how the results differed by age. A key lesson from the WHI trials, which was unfortunately lost in the posttrial cacophony, was that the risk:benefit ratio and safety profile of HT differed markedly by clinical characteristics of the participants, especially age, time since menopause, and comorbidity status. In the present review of the WHI and other recent HT trials, we aim to provide readers with an improved understanding of the importance of the timing of HT initiation, type and route of administration, and of patient-specific considerations that should be weighed when prescribing HT.

Integrity signals

Registry

Crossref · 10.1210/endrev/bnab011

Cites

339 of 339 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

4 of the 343 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Flores, V. A., Pal, L., & Manson, J. E.
Affiliations
  • Yale University (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Flores, Valerie A
Venue
Endocrine Reviews
Published
2021-04-15
Volume
42
Issue
6
Pages
720-752
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W3155312871
Cited by
174
References
343
Citations by year
2026: 40 · 2025: 45 · 2024: 44 · 2023: 30 · 2022: 13 · 2021: 2
FWCI
3.45
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
hormone therapy, menopause, vasomotor symptoms, genitourinary syndrome of menopause, bone health, coronary artery disease, all-cause mortality, Women's Health Initiative, estrogen-progestin, estrogen-only therapy, timing of hormone therapy initiation, route of administration, risk-benefit assessment
MeSH terms
Estrogens, Female, Humans, Menopause, Estrogen Replacement Therapy, Women's Health, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review